{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T12:07:52Z","timestamp":1791634072069,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.rmed.2014.02.009","type":"journal-article","created":{"date-parts":[[2014,2,20]],"date-time":"2014-02-20T12:30:18Z","timestamp":1392899418000},"page":"737-744","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Multicentric study on the beta-blocker use and relation with exacerbations in COPD"],"prefix":"10.1016","volume":"108","author":[{"given":"Luis","family":"Puente-Maestu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Calle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Ortega-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Fuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cruz","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"M\u00e1rquez-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Jorge","family":"Marcos-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Calero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Luis","family":"Rodr\u00edguez-Hermosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Malo de Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Aburto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Sobradillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardino","family":"Alc\u00e1zar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Tirado-Conde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2014.02.009_bib1","series-title":"Global strategy for the diagnosis, management and prevention of COPD. 2013","author":"Global Initiative for Chronic Obstructive Lung Disease (GOLD)","year":"2013"},{"key":"10.1016\/j.rmed.2014.02.009_bib2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000281880","article-title":"Prevalence of comorbidities in patients with chronic obstructive pulmonary disease","volume":"80","author":"Cazzola","year":"2010","journal-title":"Respiration"},{"key":"10.1016\/j.rmed.2014.02.009_bib3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/eurjhf\/hfq040","article-title":"Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme","volume":"12","author":"Hawkins","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.rmed.2014.02.009_bib4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/thx.2006.072348","article-title":"Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee","volume":"62","author":"McGarvey","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2014.02.009_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2014.02.009_bib6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199808203390801","article-title":"Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction","volume":"339","author":"Gottlieb","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmed.2014.02.009_bib7","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0954-6111(03)00168-9","article-title":"Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis","volume":"97","author":"Salpeter","year":"2003","journal-title":"Respir Med"},{"key":"10.1016\/j.rmed.2014.02.009_bib8","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.jacc.2011.02.020","article-title":"Heart failure and chronic obstructive pulmonary disease the quandary of beta-blockers and beta-agonists","volume":"57","author":"Hawkins","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rmed.2014.02.009_bib9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.arbres.2012.04.001","article-title":"Spanish COPD guidelines (GesEPOC): pharmacological treatment of stable COPD. Spanish Society of Pulmonology and Thoracic surgery","volume":"48","author":"Miravitlles","year":"2012","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.rmed.2014.02.009_bib10","first-page":"310","article-title":"Update in diagnosis and therapy of coexistent chronic obstructive pulmonary disease and chronic heart failure","volume":"4","author":"Zeng","year":"2012","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.rmed.2014.02.009_bib11","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0002-9343(92)90196-I","article-title":"Prevalence and prognosis of chronic obstructive pulmonary disease among 5839 consecutive patients with acute myocardial infarction. SPRINT Study Group","volume":"93","author":"Behar","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.rmed.2014.02.009_bib12","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/S0735-1097(01)01225-6","article-title":"Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma","volume":"37","author":"Chen","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rmed.2014.02.009_bib13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/thx.2007.081893","article-title":"Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD","volume":"63","author":"Dransfield","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2014.02.009_bib14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1164\/rccm.200803-384OC","article-title":"Impact of cardioselective beta-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis","volume":"178","author":"van Gestel","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2014.02.009_bib15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/eurjhf\/hfp160","article-title":"Primary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in Scotland","volume":"12","author":"Hawkins","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.rmed.2014.02.009_bib16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2466-12-48","article-title":"Beta-blocker use and COPD mortality: a systematic review and meta-analysis","volume":"12","author":"Etminan","year":"2012","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.rmed.2014.02.009_bib17","doi-asserted-by":"crossref","first-page":"d2549","DOI":"10.1136\/bmj.d2549","article-title":"Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study","volume":"342","author":"Short","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.rmed.2014.02.009_bib18","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.recesp.2011.05.023","article-title":"How beta-blockers are used in Spain? Analysis of limitations in their use in internal medicine and cardiology: CARACTER-BETA study","volume":"64","author":"Garcia-Moll","year":"2011","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.rmed.2014.02.009_bib19","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.amjcard.2012.10.041","article-title":"Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF)","volume":"111","author":"Mentz","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.rmed.2014.02.009_bib20","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1378\/chest.11-2032","article-title":"The impact of COPD on management and outcomes of patients hospitalized with acute myocardial infarction: a 10-year retrospective observational study","volume":"141","author":"Stefan","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2014.02.009_bib21","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.jacc.2010.01.024","article-title":"Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial","volume":"55","author":"Jabbour","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rmed.2014.02.009_bib22","doi-asserted-by":"crossref","first-page":"e61735","DOI":"10.1371\/journal.pone.0061735","article-title":"Primary medication non-adherence after discharge from a general internal medicine service","volume":"8","author":"Fallis","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.rmed.2014.02.009_bib23","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1378\/chest.123.6.1964","article-title":"Risk of mortality and heart failure exacerbations associated with inhaled beta-adrenoceptor agonists among patients with known left ventricular systolic dysfunction","volume":"123","author":"Au","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2014.02.009_bib24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2147\/COPD.S1516","article-title":"Cardiovascular morbidity and the use of inhaled bronchodilators","volume":"3","author":"Macie","year":"2008","journal-title":"Int J Chron Obstruct Pulm Dis"},{"key":"10.1016\/j.rmed.2014.02.009_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pupt.2009.10.001","article-title":"Pharmacological modulation of beta-adrenoceptor function in patients with coexisting chronic obstructive pulmonary disease and chronic heart failure","volume":"23","author":"Matera","year":"2010","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.rmed.2014.02.009_bib26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cardfail.2012.02.002","article-title":"Bronchodilators in heart failure patients with COPD: is it time for a clinical trial?","volume":"18","author":"Mentz","year":"2012","journal-title":"J Card Fail"},{"key":"10.1016\/j.rmed.2014.02.009_bib27","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1183\/09031936.00195212","article-title":"Characteristics, stability and outcomes of the gold 2011 copd groups in the eclipse cohort","volume":"42","author":"Agusti","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2014.02.009_bib28","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/thoraxjnl-2013-203270","article-title":"GOLD classifications and mortality in chronic obstructive pulmonary disease: the HUNT Study, Norway","volume":"68","author":"Leivseth","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2014.02.009_bib29","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1378\/chest.121.3.846","article-title":"Association between inhaled beta-agonists and the risk of unstable angina and myocardial infarction","volume":"121","author":"Au","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2014.02.009_bib30","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ajem.2007.07.002","article-title":"Beta-agonists for patients with chronic obstructive pulmonary disease and heart disease?","volume":"26","author":"Parker","year":"2008","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.rmed.2014.02.009_bib31","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1592\/phco.27.5.684","article-title":"Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers","volume":"27","author":"Brooks","year":"2007","journal-title":"Pharmacotherapy"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611114000821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611114000821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:29:42Z","timestamp":1760614182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611114000821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0954611114000821"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2014.02.009","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multicentric study on the beta-blocker use and relation with exacerbations in COPD","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2014.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}